Precision BioSciences Inc (DTIL)vsInsmed Inc (INSM)
DTIL
Precision BioSciences Inc
$6.40
-1.84%
HEALTHCARE · Cap: $161.22M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 1670% more annual revenue ($606.42M vs $34.26M). INSM leads profitability with a -2.1% profit margin vs -133.5%. DTIL earns a higher WallStSmart Score of 45/100 (D+).
DTIL
Hold45
out of 100
Grade: D+
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 36.6%
Revenue surging 52.6% year-over-year
Reasonable price relative to book value
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -62.7% — below average capital efficiency
Negative free cash flow — burning cash
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DTIL
The strongest argument for DTIL centers on Operating Margin, Revenue Growth, Price/Book. Revenue growth of 52.6% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : DTIL
The primary concerns for DTIL are EPS Growth, Market Cap, Return on Equity.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
DTIL profiles as a hypergrowth stock while INSM is a turnaround play — different risk/reward profiles.
DTIL carries more volatility with a beta of 1.32 — expect wider price swings.
DTIL is growing revenue faster at 52.6% — sustainability is the question.
DTIL generates stronger free cash flow (-11M), providing more financial flexibility.
Bottom Line
DTIL scores higher overall (45/100 vs 39/100) and 52.6% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Precision BioSciences Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
Visit Website →Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?